SCHEMBL21708656

SCHEMBL21708656

CCCC(F)OC(=O)CC(C)(CN)c1c(F)cccc1OC

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.35
TAS1R1 Q7RTX1 2/20 0.35
PTGFR P43088 1/20 0.35
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
TSHR P16473 2/20 0.32
KMT2A Q03164 1/20 0.32
PDE4D Q08499 1/20 0.31
PKM P14618 1/20 0.31
CRHBP P24387 1/20 0.31
CRHR2 Q13324 1/20 0.31
NPC1 O15118 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
KAT6A Q92794 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708725 0.86 SMN1; SMN2 (0.35) KMT2ASMN1; SMN2GAA
SCHEMBL21708743 0.84 MEN1 (0.41) TAS1R3TAS1R1TSHRKMT2ASMN1; SMN2
SCHEMBL21708769 0.83 TAS1R3 (0.34) TAS1R3TAS1R1PTGFRTSHRKMT2A
SCHEMBL21708772 0.82 PTGFR (0.34) TAS1R3TAS1R1PTGFRKMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL21708672 0.81 NR3C1 (0.36) TAS1R3TAS1R1
Hydrochloric Acid SCHEMBL21708632 0.81 PTGFR (0.33) TAS1R3TAS1R1PTGFRKMT2ASMN1; SMN2
SCHEMBL21708652 0.81 TAS1R3 (0.34) TAS1R3TAS1R1
SCHEMBL21656118 0.80 MTNR1A (0.41) PTGFRKMT2ANPC1SMN1; SMN2KAT6A
SCHEMBL21631951 0.79 PTGFR (0.46) PTGFRKMT2ANPC1SMN1; SMN2GAA
SCHEMBL21708773 0.76 TAS1R3 (0.33) TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed